MOGRIFY LTD has a total of 14 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are MPEG LA LLC, ARGONAUTE RNA LTD and BBHC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 | |
#8 | Israel | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Gough Julian | 12 |
#2 | Rackham Owen | 6 |
#3 | Kafienah Wael | 6 |
#4 | Cooper-White Justin | 5 |
#5 | Wael Kafienah | 1 |
#6 | Hayashizaki Yoshihide | 1 |
#7 | Firas Jaber | 1 |
#8 | Polo Jose | 1 |
#9 | Julian Gough | 1 |
Publication | Filing date | Title |
---|---|---|
GB202020456D0 | Cell reprogramming | |
CA3067862A1 | Cell reprogramming methods for producing chondrocytes | |
AU2018286654A1 | Cell reprogramming to cardiomyocytes | |
AU2016378989A1 | Cell reprogramming |